TY - JOUR
T1 - Contraceptive strategies for reducing the risk of reproductive cancers
AU - FIGO Committee on Contraception
AU - FIGO Committee on Women's Cancer
AU - Aliabadi, A. R.
AU - Wilailak, Sarikapan
AU - McNally, Orla
AU - Berek, Jonathan S.
AU - Sridhar, Aparna
AU - Sheffield, Jill
AU - Kasliwal, Asha
AU - Musinguzi, Jotham
AU - González, Cuauhtemoc Celis
AU - Ahsan, Azra
AU - Mola, Glen
AU - Roy, Priyankur
AU - Lam, Wai cheung
AU - Serrano, Miguel Antonio Guidos
AU - Askew, Ian
AU - Ten Hoope-Bender, Petra
AU - Tyson, Nichole
AU - Townsend, John
AU - Makins, Anita
AU - Fuchs-Montgomery, Nomi
AU - Cobley, Bethan
AU - Kehoe, Sean
AU - Pomerantz, Tali
AU - Lindeque, Gerhard
AU - Anorlu, Rose
AU - Scambia, Giovanni
AU - Okamoto, Aikou
AU - Schmalfeldt, Barbara
AU - Pareja, Rene
AU - Berek, Jonathan
AU - Creutzberg, Carien
AU - Mutch, David
AU - Matias-Guiu, Xavier
AU - Fotopoulou, Christina
N1 - Publisher Copyright:
© 2024 International Federation of Gynecology and Obstetrics.
PY - 2024/7
Y1 - 2024/7
N2 - Reproductive cancers, encompassing various malignancies like endometrial, ovarian, cervical cancer, and gestational trophoblastic neoplasia, pose a significant global health burden. Understanding their patterns is vital for effective prevention and management. Contraceptives show a protective effect against some of these cancers. This clinical guidance document aims to elucidate the disease burden of reproductive cancers and the evidence supporting contraceptive methods in prevention and management. Regional disparities in incidence and mortality highlight the urgent need for targeted interventions, particularly in low-resource settings. Healthcare providers must weigh individual risk profiles and medical eligibility criteria when discussing contraceptive options. Enhanced health literacy through direct patient education is essential for leveraging low-cost behavioral interventions to mitigate reproductive cancer risks.
AB - Reproductive cancers, encompassing various malignancies like endometrial, ovarian, cervical cancer, and gestational trophoblastic neoplasia, pose a significant global health burden. Understanding their patterns is vital for effective prevention and management. Contraceptives show a protective effect against some of these cancers. This clinical guidance document aims to elucidate the disease burden of reproductive cancers and the evidence supporting contraceptive methods in prevention and management. Regional disparities in incidence and mortality highlight the urgent need for targeted interventions, particularly in low-resource settings. Healthcare providers must weigh individual risk profiles and medical eligibility criteria when discussing contraceptive options. Enhanced health literacy through direct patient education is essential for leveraging low-cost behavioral interventions to mitigate reproductive cancer risks.
KW - cancer
KW - contraception
KW - gynecology
KW - prevention
KW - reproductive health
UR - https://www.scopus.com/pages/publications/85192536008
U2 - 10.1002/ijgo.15567
DO - 10.1002/ijgo.15567
M3 - Review article
C2 - 38725288
AN - SCOPUS:85192536008
SN - 0020-7292
VL - 166
SP - 141
EP - 151
JO - International Journal of Gynecology and Obstetrics
JF - International Journal of Gynecology and Obstetrics
IS - 1
ER -
SDG 3 Good Health and Well-being